Cytochrome c oxidase (COX) is encoded by three additional patients with histochemically defined COX deficiency also had this pattern of staining, suggesting mitochondrial and nine nuclear genes. COX deficiency is genetically heterogeneous but current diagnostic that they had mtDNA defects. Clinical features in this group were heterogeneous, including infantile methods cannot easily distinguish between mitochondrial and nuclear defects. We hypothesized that there may encephalopathy, multisystem disease, cardiomyopathy and childhood-onset isolated myopathy. The remaining be differential expression of COX subunits depending on the underlying mutation. COX subunit expression patients did not have the same pattern of immunostaining. Fourteen had reduced staining of all was investigated in five patients with known mtDNA mutations. Severe and selective reduction of mtDNAsubunits, whilst 10 had normal staining of all subunits despite reduced enzyme activity. Patients with COX encoded COX subunits I and II was consistently observed in all these patients and was restricted to COXdeficiency secondary to mtDNA mutations have a specific pattern of subunit loss, but the majority of deficient fibres. Immunostaining of nuclear-encoded subunits COX IV and Va was normal, whilst subunit children with COX deficiency do not have this pattern of subunit loss and are likely to have nuclear gene defects. VIc, also nuclear-encoded, was decreased. Twelve of 36
Introduction
Cytochrome c oxidase (COX), or complex IV of the encoded, synthesized on cytosolic ribosomes and subsequently transported into the mitochondria. It is mitochondrial respiratory chain, catalyses the transfer of electrons from reduced cytochrome c to molecular oxygen, postulated that the nuclear subunits may be involved in the assembly or stability of the holoenzyme complex, and/or may and couples this reaction to proton pumping across the inner mitochondrial membrane. The human enzyme is composed have regulatory functions by binding ligands that modulate the catalytic function of the enzyme. of 13 polypeptide subunits that are of dual genetic origin. The three major subunits (I, II and III) constitute the catalytic COX deficiency, either total or partial, is the most commonly recognized respiratory chain defect in childhood core of the enzyme (Capaldi, 1990) and are encoded by mitochondrial DNA (mtDNA). The mitochondrial genome is (Caruso et al., 1996) . This may be an isolated defect or may be combined with deficiencies of other components of the a maternally inherited circular 16 569 bp (base pair) doublestranded DNA molecule encoding 22 transfer RNAs (tRNAs), respiratory chain. The availability of a reliable cytochemical method to visualize COX activity (Seligman et al., 1968 ) two ribosomal RNAs and 10 other respiratory chain enzyme subunits in addition to the three subunits of COX (Anderson means that COX deficiency can be detected in very small muscle biopsies, even when there is insufficient tissue for et al., 1981) . The remaining subunits of COX (IV, Va, Vb, VIa, VIb, VIc, VIIa, VIIb, VIIc and VIII) are nuclearmeasurement of enzyme activity. Clinical presentations are 
very heterogeneous and include fatal infantile myopathy . These syndromes are associated with mtDNA mutations, and the COX deficiency is patchy or without a Fanconi-type renal tubulopathy (DiMauro et al., 1980) , Leigh syndrome (subacute necrotizing encephalowith some fibres deficient and others apparently normal, reflecting the heteroplasmy of the mutations. A critical mutant myelopathy) (Willems et al., 1977; Rahman et al., 1996) , cardiomyopathy and myopathy (Zeviani et al., 1986) , load is required to produce a biochemical defect, and fibres with mutant loads below this threshold appear histochemically recurrent myoglobinuria (Saunier et al., 1995; Keightley et al., 1996) and a 'benign' spontaneously reversible COXnormal (Schon et al., 1997) .
Mutations have been identified in all three mtDNA-encoded deficient myopathy (DiMauro et al., 1983) . In addition, partial COX deficiency may be seen in certain well-recognized COX subunit genes. Most reported mutations are in the COX subunit III gene: a 15 bp microdeletion in a highly conserved mitochondrial syndromes, such as the Kearns-Sayre, MELAS (mitochondrial encephalomyopathy with lactic acidosis and region of the gene was associated with recurrent myoglobinuria and myopathy in a 15-year-old girl (Keightley stroke-like episodes) and MERRF (myoclonus epilepsy and ragged red fibres) syndromes (Johnson et al., 1983; Hammans et al., 1996) ; a missense mutation at position 9957 was found F ϭ female; M ϭ male; y ϭ year(s); m ϭ month(s); d ϭ day(s); C ϭ consanguineous; ND ϭ not determined; LS ϭ Leigh syndrome; PN ϭ peripheral neuropathy. The lactate range refers to measurements from the same patient on different occasions. Reference ranges for blood and CSF lactate and lactate : pyruvate ratios are given in brackets. ↓ ϭ Respiratory chain enzyme complex activity below the control range. * Patients with COX activity at the bottom of the normal range but with some COX-negative fibres on histochemistry; † patient with COX activity at the bottom end of the normal range and without COX-negative fibres, but in whom histochemical staining for COX was weaker than in a control biopsy stained alongside (on the same slide); ‡ assays performed in cultured skin fibroblasts.
in an adult with MELAS (Manfredi et al., 1995) ; and a stop disease (Comi et al., 1998) . Recently, a point mutation in the initiation codon of the COX subunit II gene was reported mutation at nucleotide 9952 was described in a 36-year-old woman suffering from episodes of encephalopathy associated in a patient with encephalomyopathy (Clark et al., 1999) . As most subunits of COX are nuclear-encoded and with lactic acidaemia, exercise intolerance and proximal myopathy (Hanna et al., 1998b) . A heteroplasmic 5 bp additional nuclear-encoded factors are essential for assembly of the holoenzyme complex, it is likely that most cases of microdeletion in the mitochondrial COX subunit I gene has been described in association with severe isolated muscle COX deficiency are caused by nuclear gene mutations. However, mutations have yet to be described in the nuclear COX deficiency in a patient with atypical motor neuron COX subunit genes, despite extensive sequence analysis mtDNA deletion in association with clinical features of the Pearson and Kearns-Sayre syndromes (McShane et al., 1991) . (Adams et al., 1997; Lee et al., 1998) . Characterization of human nuclear-encoded assembly and import factors and Three normal control biopsies had no histological evidence of muscle disease. Three other biopsies with normal other nuclear regulatory genes for COX is still in its infancy. Recently, mutations have been identified in the SURF1 gene quantitative COX activity were obtained from patients with congenital lactic acidosis associated with isolated deficiencies on chromosome 9 in patients with Leigh syndrome and COX deficiency (Tiranti et al., 1998; Zhu et al., 1998) . The SURF1 of pyruvate carboxylase, the pyruvate dehydrogenase complex (PDHC) and complex I of the respiratory chain. gene product is thought to be involved in COX assembly or maintenance.
Thus, most patients with COX deficiency remain uncharacterized at the molecular level. In the absence of an
Material and methods
Open or needle muscle biopsies were performed under identified mtDNA mutation or a strong maternal family history of neuromuscular disease it is difficult to be certain general anaesthesia and snap frozen immediately in hexane maintained in an acetone/CO 2 bath at -80°C. After sectioning whether the genetic defect is mitochondrial or nuclear in individual cases. This leads to difficulties in genetic for diagnostic purposes, they were stored at -50°C until the time of this study. counselling. We sought to determine whether COX subunit expression patterns detected immunohistochemically, using highly specific monoclonal antibodies, can distinguish between mtDNA defects and nuclear DNA defects in COX
Histochemistry
For histochemical studies, cryostat sections cut at 10 µm deficiency. This would be an invaluable aid to genetic counselling and would help to direct subsequent molecular were stained to demonstrate the activities of succinate dehydrogenase (SDH) and COX using standard methods genetic investigations. In addition, studying patterns of subunit expression in COX-deficient patients is fundamental (Filipe and Lake, 1990; Stoward and Pearse, 1991) . Sections were also stained with the modified Gomori trichrome, and to understanding the pathogenesis of respiratory chain enzyme deficiencies.
for glycogen and fat. Muscle fibres were typed using standard ATPase techniques, with and without acid preincubation.
Patients Antibodies
Muscle biopsies with decreased or absent COX activity, as A battery of subunit-specific monoclonal antibodies was used determined by histochemistry, were identified retrospectively to identify COX subunits immunohistochemically. Mouse from the histopathological records at Great Ormond Street monoclonal antibodies directed against subunits I and II Hospital for Children. These muscle biopsies had been (mitochondrial-encoded) and IV, Va and VIc (nuclearobtained, after informed parental consent, for diagnostic encoded) were used (Taanman et al., 1996) . A mouse purposes from children with suspected respiratory chain monoclonal antibody directed against fast myosin disorders over a 12-year period . Patients were (Novocastra, Newcastle-upon-Tyne, UK) was used to identify excluded from the study only if no frozen muscle remained.
type I and type II muscle fibres. We studied 36 children with reduced COX staining in biopsied skeletal muscle in whom the molecular defect was uncertain. Clinical features are summarized in Table 1 (P1 to P36).
Immunohistochemistry
Patients were aged between 5 days and 15 years 10 months Serial 8-µm cryostat sections were cut from patient and (median 1 year 5 months) at the time of biopsy, the majority control biopsies, mounted adjacently on polysine slides (BDH, being infants. There was a male preponderance of 1.8 : 1.
Poole, UK) and air-dried for 1 h. Mouse monoclonal Lactate levels were raised in the blood and/or CSF in 34 of antibodies directed against COX subunits and fast myosin 35 patients. Lactate : pyruvate ratios were determined in 19
were optimally diluted in phosphate-buffered saline (PBS), patients and were elevated in 16 of these. Nine patients had pH 7.4, and 200 µl of each was applied to serial sections for Leigh syndrome, defined by clinical features, lactic acidosis each patient and control. Sections were incubated with and neuroimaging.
primary antibody overnight in a humidified chamber to We also examined muscle from five patients with known prevent dehydration. One set of sections was incubated in mtDNA defects (C1 to C5 in Table 1 ). Three had point PBS alone, without primary antibody, as a control. All mutations involving tRNA genes: insertion of a cytosine at sections were washed in PBS and then incubated for 45 min nucleotide position 7472 in patient C1 (Hanna et al., 1998a) ; in biotinylated rabbit anti-mouse IgG secondary antibody T14709C in patient C2 (Hanna et al., 1995) ; and A8344G (Dako, Glostrup, Denmark). The immunoreaction was in patient C5 (Sweeney et al., 1994) . Patient C4 had a point visualized after a 45 min incubation in streptavidinmutation in the COX subunit III gene (G9952A) (Hanna biotinylated horseradish peroxidase complex (ABC complex, Dako) by developing the peroxidase activity in a solution et al., 1998b) whilst patient C3 had the 'common' 4.9 kb containing 0.05% 3,3Ј-diaminobenzidine hydrochloride fell into two groups, defined by their immunostaining. In those biopsies in which fibres were COX-positive by (DAB) and 0.03% hydrogen peroxide in PBS for 10 min. Sections were washed with PBS between each step of the histochemistry, these same fibres stained positively with the range of COX monoclonal antibodies used. For COX-negative procedure, and finally in tap water for 10 min after incubating in DAB. Carazzi's haematoxylin was used as a nuclear fibres, however, the pattern of immunostaining varied according to the classification outlined. counterstain. Sections were dehydrated, cleared and mounted in DPX. All incubations were at room temperature.
Group 1 (Table 2)
Ten of the COX-deficient patients with unknown aetiology
Results

had a pattern of COX immunostaining similar or identical to
Histochemistry that of the five patients with mtDNA mutations (Fig. 1) . One All patients had reduced COX activity on histochemical of these patients (P26) had reduction of subunit II only, with staining. In some cases there was complete absence of COX normal staining of subunit I. Subunit VIc was also reduced staining, whilst in others there was a more patchy loss, with in six of these 10 patients, including the patient with isolated variation in staining intensity unrelated to fibre type (Table  reduced staining of subunit II. This group of patients was 2). In 15 patients, the decreased COX staining activity shown clinically heterogeneous, including patients with histochemically was associated with COX enzyme activity encephalopathy in infancy, multisystem disease, cardiobelow the normal range on biochemical assay (Table 1) . In myopathy and isolated myopathy. Screening for mtDNA four patients, COX activity was at the bottom end of the deletions, point mutations at nucleotides 3243, 8344 and normal range. In three of these there were some COX-8993 and for mtDNA depletion was negative in these 10 negative fibres on histochemistry, whilst the fourth had patients. Two other patients, with mtDNA depletion on weaker histochemical staining for COX than a control biopsy Southern blot analysis of muscle DNA, also had selective stained alongside on the same slide. There was insufficient loss of mtDNA-encoded subunits (patients P9 and P23 in material for performing enzyme assays in the other patients. Table 2 ), whereas a third patient with mtDNA depletion had All but two patients (P14 and P20) had increased neutral patchy loss of staining of all subunits (P29). lipid droplets within their muscle fibres. Only three cases (P1, P9 and P15) had classical ragged red fibres on Gomori trichrome staining, but 20 had evidence of mitochondrial Group 2 (Table 2) proliferation suggested by increased SDH staining.
The majority of patients did not have the same pattern of immunostaining as those with known mtDNA mutations. Thirteen patients had reduced staining of all subunits (group Immunohistochemistry 2A in Table 2 ), whilst 10 had normal staining of all subunits Clear particulate immunoreactivity consistent with despite reduced COX activity on histochemical staining mitochondrial staining was observed in muscle fibres from (group 2B in Table 2 ). normal control biopsies with all antibodies directed against COX subunits. Permeabilization, as used by Johnson and colleagues (Johnson et al., 1988) , had no effect on the Discussion staining intensity in control samples and was not used in this
As neither clinical, biochemical nor histochemical features study. Immunoreactivity was more prominent in type I fibres, enable patients with mtDNA or nuclear mutations to be which have a higher mitochondrial content. No differentiated reliably, we sought to determine whether COX immunostaining was observed in sections incubated with subunit expression patterns detected immunohistochemically PBS, pH 7.4, in place of primary antibody, as a negative can distinguish between mtDNA defects and nuclear defects control. Patients with proven pyruvate carboxylase, PDHC in COX deficiency. and isolated complex I deficiency also had normal immunostaining of all COX subunits as well as normal COX activity.
COX subunit expression pattern in patients with mtDNA mutations
Selective and marked reduction of mtDNA-encoded COX
mtDNA mutations
All five patients with known mtDNA mutations had an subunits I and II was observed in all five patients with a known mtDNA mutation. This reduction was restricted to identical pattern of COX subunit immunostaining, with selective loss of staining of mitochondrial subunits I and II, COX-deficient fibres, all subunits appearing normal in COXpositive fibres. In addition, less marked reduction of the together with reduced staining of subunit VIc (Fig. 1) . This reduction was limited to COX-deficient fibres. All subunits nuclear-encoded COX subunit VIc was also observed in COX-deficient fibres in these patients. Immunostaining with stained normally in COX-positive fibres. The other 36 patients Table 2 .
Results of COX immunohistochemistry
This refers to intensity of staining, either histochemical for COX, or immunohistochemical with COX subunit antibodies. 'Patchy' refers to variation in staining intensity unrelated to fibre typing.
antibodies directed against nuclear-encoded subunits COX 1996), a point mutation in the mitochondrial tRNA leu(CUN) gene (Fu et al., 1996) and a 15-bp microdeletion in the COX IV and Va, however, was normal in all muscle fibres from all five patients with known mtDNA mutations.
III gene (Keightley et al., 1996) . Levels of COX subunit IV were preserved in the patients studied by Mita and colleagues Selective loss of mitochondrial-encoded COX subunits has been observed previously in patients with mtDNA deletions (Mita et al., 1989) , Moraes and colleagues (Moraes et al., 1992) and Fu and colleagues (Fu et al., 1996 antibodies against other nuclear-encoded subunits were used 1991; Tritschler et al., 1992 ; Macmillan and Shoubridge, in these studies and so the fate of other nuclear-encoded 1996; Marusich et al., 1997) . Eight COX subunits was not determined in these patients. Taanman had selective loss of mitochondrial-encoded subunits (I and/ and colleagues examined immunostaining of COX Va, Vb or II), with variable loss of nuclear subunits. Two patients, and VIc as well as IV in a patient with chronic progressive however, had homogeneous reduction of all COX subunits external ophthalmoplegia harbouring a mtDNA deletion, and compared with controls. In our study, two patients with found greatly reduced levels of COX I, II, Va, Vb and VIc mtDNA depletion had loss of mitochondrial-encoded subunits in COX-negative fibres, with relatively preserved levels of whilst a third had loss of all subunits. We therefore confirm COX IV (Taanman et al., 1996) . The patient with the COX that different patterns of subunit expression may be seen in III microdeletion had little or no reactivity with antibodies this syndrome. This may reflect genetic heterogeneity or, to COX I and VIc but intact immunostaining of subunit IV alternatively, may be related to the stage in the course of the (Keightley et al., 1996) . Immunoblot analyses have also disease . A recent study of human demonstrated relative preservation of COX IV and Va and leukaemic cells (Molt-cells) which lack mitochondrial protein reduction of COX VIc in ρ 0 cells lacking mtDNA-encoded synthesis suggested that all COX subunits are lost if the subunits (Taanman et al., 1996; Marusich et al., 1997) .
mitochondrial translation defect is sufficiently severe Differential loss of immunostaining of nuclear-encoded (Nijtmans et al., 1995b) . Studies of ρ 0 cells, which lack COX subunits in patients with known mtDNA mutations mtDNA, have yielded similar results (Taanman et al., 1996 ; may be related to the quaternary structure of the holoenzyme, Marusich et al., 1997) . which was recently determined for the bovine enzyme (Tsukihara et al., 1996) . Subunit VIc forms a dumb-bell, with a transmembrane helix in contact with helix I of subunit Other COX subunit expression patterns II. It is possible that the stability of subunit VIc may be
The remainder of our group of patients had COX subunit impaired when there are reduced levels of subunit II, since patterns falling into one of two broad groups: intact staining the two subunits are intimately related. Subunits IV and Va, of all subunits tested, or reduced staining of all subunits. We on the other hand, have interactions with several nuclear postulate that these patients are likely to have nuclear DNA subunits. These may form stable partial complexes in the defects. To date no mutations have been described in nuclearabsence of mitochondrial subunits.
encoded COX subunits; therefore, patients with known In the present study, the COX-deficient patients who had mutations cannot be used for comparison. However, pedigree loss of subunits I and II were not typical of the group of analysis indicates autosomal recessive inheritance in some patients usually associated with mtDNA defects. Some of distinct clinical entities associated with COX deficiency, such the patients presented in the neonatal period with congenital as fatal infantile myopathy and Leigh syndrome (Rahman lactic acidosis, variably associated with encephalomyopathy, et al., 1996) . The present study suggests that Leigh syndrome cardiomyopathy, liver disease and renal tubulopathy. Two associated with COX deficiency is aetiologically had Leigh syndrome confirmed neuropathologically. In the past these patients may have been assumed to have nuclear heterogeneous. Two patients had loss of immunostaining of defects. Three patients did have a ragged-red fibre myopathy mitochondrial subunits (including one with the mtDNA presenting late in childhood, a common phenotype associated depletion syndrome) whilst others had loss of staining of all with mtDNA defects. One of these had selective loss of subunits or normal staining of all subunits. Sequence analysis subunit II with normal immunostaining of subunit I. A point of the SURF1 gene is in progress in these patients with mutation has been identified in the COX subunit II gene in COX-deficient Leigh syndrome. this patient, who is described in detail elsewhere (Rahman In patients with intact immunostaining of all subunits et al., 1999). Loss of COX II immunostaining in this patient despite reduced or absent COX staining, there seems to be was associated with reduced immunostaining of subunit VIc.
reduced function despite apparently normal assembly of the This may be seen as further evidence that subunit II is holoenzyme. These patients may have a kinetic defect. A required for stability of subunit of VIc. None of the 12 single patient with COX deficiency has been described patients with selective loss of mtDNA-encoded COX subunits who had an altered K m (Michaelis constant) for reduced in this study has the common mtDNA point mutations at cytochrome c (Nijtmans et al., 1995a) . Studies in cultured nucleotides 3243, 8344 or 8993. Southern blot analysis has fibroblasts from this patient revealed decreased COX activity revealed mtDNA depletion in two of these patients, including but normal synthesis, assembly and stability of both one with pathologically proven Leigh syndrome. Direct mitochondrial and nuclear-encoded COX subunits. This sequencing of mtDNA is in progress for the remaining patient was thought to have a defect in one of the nuclear nine patients.
subunits of the enzyme, as mtDNA analysis failed to identify a mutation and the parents were consanguineous. In other
COX subunit expression patterns in the mtDNA
patients it is theoretically possible that a mtDNA defect involving a COX gene could alter the kinetic properties of depletion syndrome the enzyme but allow normal assembly and therefore normal COX subunit expression has been studied previously in 10 patients with the mtDNA depletion syndrome (Moraes et al., immunostaining of COX subunits.
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